Identification of microRNA editing sites in clear cell renal cell carcinoma

Yulong Liu1, Shiyong Guo2, Wenping Xie2,3

  • 1State Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunming, 650500, Yunnan, China.

Scientific Reports
|September 13, 2023
PubMed

Insights

This study reveals crucial microRNA (miRNA) editing events in clear cell renal cell carcinoma (ccRCC). Altered miRNA editing in ccRCC impacts gene targets, offering new insights into kidney cancer development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Clear cell renal cell carcinoma (ccRCC) is a kidney cancer with a largely unknown microRNA (miRNA) editing landscape.
  • While miRNA transcriptomes are studied, the functional impact of miRNA editing in ccRCC remains poorly understood.

Purpose of the Study:

  • To investigate the role and significance of miRNA editing events in ccRCC.
  • To identify specific miRNA editing sites and their altered levels in ccRCC compared to normal kidney tissues.

Main Methods:

  • Analysis of small RNA sequencing data from 154 ccRCC patients and 22 normal controls.
  • Identification and quantification of miRNA editing sites and their differential levels.

Main Results:

  • 1025 miRNA editing sites were identified across 246 pre-miRNAs.
  • 122 significant editing events were found in ccRCC, including A-to-I editing in hsa-mir-376a-3p and hsa-mir-376c-3p, and C-to-U editing in hsa-mir-29c-3p seed regions.
  • Edited miRNAs (hsa-mir-376a-1_49g, hsa-mir-376c_48g, hsa-mir-29c_59u) exhibited new targets, many deregulated in ccRCC.

Conclusions:

  • MiRNA editing is a significant factor in ccRCC pathogenesis.
  • Differential miRNA editing levels in ccRCC may contribute to the deregulation of novel target genes, impacting kidney cancer progression.